$BLFS News

BioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call Transcript

BioLife Solutions Inc (NASDAQ:BLFS) Q1 2026 Earnings Beat Signals Profitability Milestone

BioLife Looks Strong For Fiscal Year 2026

Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade

Should BioLife Solutions’ 2026 Profitability Guidance and Refocus Require Action From BLFS Investors?

BioLife Solutions Inc (BLFS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

BioLife Solutions, Inc. Q4 2025 Earnings Call Summary

BioLife Solutions Inc (NASDAQ:BLFS) Surpasses Q4 2025 Estimates with Surprise Profit, Stock Rises

BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates

BioLife (BLFS) Q4 2025 Earnings Call Transcript

BioLife Solutions Q4 Earnings Call Highlights

BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript

BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations

BioLife Solutions Earnings Report: Q4 Overview

BioLife Solutions Sees FY2026 Sales $112.500M-$115.000M vs $111.058M Est.

BioLife Solns Q4 Adj. EPS $0.04 Beats $(0.02) Estimate, Sales $24.764M Beat $24.082M Estimate.

BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026

BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market

BioLife Solutions And Qkine Sign Multi-Year Supply Agreement To Distribution Cytokine And Growth Factor Products For Use In Cell And Gene Therapy Manufacturing

BioLife Solutions And Qkine Sign Multi-Year Supply Agreement To Distribution Cytokine And Growth Factor Products For Use In Cell And Gene Therapy Manufacturing